Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Cash from Investing Activities (2016 - 2025)

Lisata Therapeutics filings provide 13 years of Cash from Investing Activities readings, the most recent being $5.1 million for Q3 2025.

  • For the quarter ending Q3 2025, Cash from Investing Activities rose 181.68% year-over-year to $5.1 million, compared with a TTM value of $15.1 million through Dec 2025, up 14.0%, and an annual FY2025 reading of $15.1 million, up 14.0% over the prior year.
  • Cash from Investing Activities hit $5.1 million in Q3 2025 for Lisata Therapeutics, up from $505000.0 in the prior quarter.
  • The five-year high for Cash from Investing Activities was $12.3 million in Q3 2023, with the low at -$6.3 million in Q3 2024.
  • Median Cash from Investing Activities over the past 3 years was $4.3 million (2023), compared with a mean of $3.5 million.
  • The largest YoY upside for Cash from Investing Activities was 1715.59% in 2024 against a maximum downside of 151.46% in 2024.
  • Year by year, Cash from Investing Activities stood at -$5.7 million in 2023, then surged by 124.31% to $1.4 million in 2024, then skyrocketed by 270.77% to $5.1 million in 2025.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at $5.1 million, $505000.0, and $9.4 million for Q3 2025, Q2 2025, and Q1 2025 respectively.